反应详情

First 3.76 g (24 mmol) of piperidine-4-carboxylic acid ethyl ester and then 3.1 g (24 mmol) of N-ethyl-N,N-diisopropylamine are added to a solution of 3.98 g (12 mmol) of 3-[2-(p-toluenesulphonyloxy)ethyl]chroman in 50 ml of absolute diemthylformamide. The mixture is stirred for 16 hours at 60° and, after cooling, is concentrated by evaporation under a high vacuum. Water is added to the oily residue and extraction by shaking is carried out with diethyl ether. The combined organic phases are extracted with 2N hydrochloric acid. The combined hydrochloric acid extracts are rendered alkaline, while cold, with sodium hydroxide solution (30% strength) and extracted with dichloromethane. The combined dichloromethane phases are dried over sodium sulphate and concentrated by evaporation in vacuo. 3.8 g (100%) of crude product are obtained which are chromatographed on 200 g of silica gel (0.040-0.063 mm) using ethyl acetate as the eluant. 3.7 g (97.3%) of 1-[2-(chroman-3-yl)ethyl]piperidine-4-carboxylic acid ethyl ester are then obtained in the form of a colourless oil. The 1-[2-chroman-3-yl)ethyl]-piperidine-4-carboxylic acid ethyl ester hydrochloride produced therefrom using hydrochloric acid in diethyl ether crystallises from ethanol/diethyl ether and melts at 182°-186°.

1. temperatureafter cooling
2. concentrationis concentrated by evaporation under a high vacuum
3. additionWater is added to the oily residue and extraction
4. stirringby shaking
5. extractionThe combined organic phases are extracted with 2N hydrochloric acid
6. extractionwhile cold, with sodium hydroxide solution (30% strength) and extracted with dichloromethane
7. dry with materialThe combined dichloromethane phases are dried over sodium sulphate
8. concentrationconcentrated by evaporation in vacuo
9. custom3.8 g (100%) of crude product are obtained which
10. customare chromatographed on 200 g of silica gel (0.040-0.063 mm)